The company will use the funds to move into the female health space and increase screening and preventive care.

The funds will be used to increase the development of GAIA-based Alzheimer's Disease drugs and widen the pipeline of blockbuster drug candidates.

The news comes alongside the U.S. Department of Defense’s announcement of $200 million contracts awarded to xAI, Anthropic, Google and OpenAI for AI implementation.